+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Immunohematology Tests - Medical Devices Pipeline Assessment, 2020

  • ID: 5212230
  • Report
  • November 2020
  • Region: Global
  • 64 pages
  • GlobalData

FEATURED COMPANIES

  • AbSorber AB
  • Alba Bioscience Limited
  • Amity University
  • Biofortuna Ltd
  • Calviri Inc
  • Grifols SA
Summary

The publisher's Medical Devices sector report, “Immunohematology Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Immunohematology Tests pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Immunohematology Tests includes studies of antigen-antibody reactions and analogous phenomena as they relate to the pathogenesis and clinical manifestations of blood disorders. This category includes blood typing reagents and antibody detection reagents.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Immunohematology Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Immunohematology Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Immunohematology Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbSorber AB
  • Alba Bioscience Limited
  • Amity University
  • Biofortuna Ltd
  • Calviri Inc
  • Grifols SA
1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Immunohematology Tests Overview

3 Products under Development
3.1 Immunohematology Tests - Pipeline Products by Stage of Development
3.2 Immunohematology Tests - Pipeline Products by Segment
3.3 Immunohematology Tests - Pipeline Products by Territory
3.4 Immunohematology Tests - Pipeline Products by Regulatory Path
3.5 Immunohematology Tests - Pipeline Products by Estimated Approval Date

4 Immunohematology Tests - Pipeline Products under Development by Companies
4.1 Immunohematology Tests Companies - Pipeline Products by Stage of Development
4.2 Immunohematology Tests - Pipeline Products by Stage of Development

5 Immunohematology Tests Companies and Product Overview

6 Immunohematology Tests - Recent Developments

7 Appendix
7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Immunohematology - Pipeline Products by Stage of Development
Table 2: Immunohematology - Pipeline Products by Segment
Table 3: Immunohematology - Pipeline Products by Territory
Table 4: Immunohematology - Pipeline Products by Regulatory Path
Table 5: Immunohematology - Pipeline Products by Estimated Approval Date
Table 6: Immunohematology Companies - Pipeline Products by Stage of Development
Table 7: Immunohematology - Pipeline Products by Stage of Development
Table 8: AbSorber AB Pipeline Products & Ongoing Clinical Trials Overview
Table 9: ABO Diagnostic Test - Product Status
Table 10: ABO Diagnostic Test - Product Description
Table 11: Alba Bioscience Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 12: ALBAcyte O Adult i Cell Reagent - Product Status
Table 13: ALBAcyte O Adult i Cell Reagent - Product Description
Table 14: ALBAcyte O RhD VI Reagent Cells - Product Status
Table 15: ALBAcyte O RhD VI Reagent Cells - Product Description
Table 16: Amity University Pipeline Products & Ongoing Clinical Trials Overview
Table 17: Blood Group Testing Kit - Product Status
Table 18: Blood Group Testing Kit - Product Description
Table 19: Biofortuna Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 20: HemoPlex Kell Genotyping Kit - Product Status
Table 21: HemoPlex Kell Genotyping Kit - Product Description
Table 22: HemoPlex Kidd & Duffy Genotyping Kit - Product Status
Table 23: HemoPlex Kidd & Duffy Genotyping Kit - Product Description
Table 24: HemoPlex MNS Genotyping Kit - Product Status
Table 25: HemoPlex MNS Genotyping Kit - Product Description
Table 26: HemoPlex Multi Blood Group Genotyping Kit - Product Status
Table 27: HemoPlex Multi Blood Group Genotyping Kit - Product Description
Table 28: HemoPlex RHCE Screening Kit - Product Status
Table 29: HemoPlex RHCE Screening Kit - Product Description
Table 30: HemoPlex RHCE Variant Genotyping Kit - Product Status
Table 31: HemoPlex RHCE Variant Genotyping Kit - Product Description
Table 32: HemoPlex RHD & CE Genotyping Kit - Product Status
Table 33: HemoPlex RHD & CE Genotyping Kit - Product Description
Table 34: HemoPlex RHD Variant Genotyping Kit - Product Status
Table 35: HemoPlex RHD Variant Genotyping Kit - Product Description
Table 36: ThromboPlex HPA Screening Kit - Product Status
Table 37: ThromboPlex HPA Screening Kit - Product Description
Table 38: Calviri Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: Blood Screening Immunosignaturing - Product Status
Table 40: Blood Screening Immunosignaturing - Product Description
Table 41: Grifols SA Pipeline Products & Ongoing Clinical Trials Overview
Table 42: IH Blood Genotyping (D) Kit - Product Status
Table 43: IH Blood Genotyping (D) Kit - Product Description
Table 44: Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 45: ORTHO AutoVue - Rare Sera Assay - Product Status
Table 46: ORTHO AutoVue - Rare Sera Assay - Product Description
Table 47: ORTHO BioVue - Rare Sera Assay - Product Status
Table 48: ORTHO BioVue - Rare Sera Assay - Product Description
Table 49: Quotient Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Eluate Kit - Product Status
Table 51: Eluate Kit - Product Description
Table 52: Expanded IH Microarray - Product Status
Table 53: Expanded IH Microarray - Product Description
Table 54: IH Microarray Patient - Product Status

List of Figures
Figure 1: Immunohematology - Pipeline Products by Stage of Development
Figure 2: Immunohematology - Pipeline Products by Segment
Figure 3: Immunohematology - Pipeline Products by Territory
Figure 4: Immunohematology - Pipeline Products by Regulatory Path
Figure 5: Immunohematology - Pipeline Products by Estimated Approval Date
Note: Product cover images may vary from those shown
  • AbSorber AB
  • Alba Bioscience Limited
  • Amity University
  • Biofortuna Ltd
  • Calviri Inc
  • Grifols SA
  • Ortho-Clinical Diagnostics Inc
  • Quotient Ltd
  • SiDx Inc
Note: Product cover images may vary from those shown
Adroll
adroll